Rational Advisors LLC Amarin Corp Plcuk Transaction History

Rational Advisors LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 12, 2020	SELL	$3.64 - $7.76 $414,960 - $884,640	-114,000 Closed	0 $0
Q2 2020 Aug 10, 2020	BUY	$4.78 - $8.26 $544,920 - $941,640	114,000 New	114,000 $789,000
Q1 2020 May 12, 2020	SELL	$4.0 - $21.53 $921,200 - $4.96 Million	-230,300 Closed	0 $0
Q4 2019 Feb 06, 2020	BUY	$13.94 - $24.12 $977,194 - $1.69 Million	70,100 Added 43.76%	230,300 $4.94 Million
Q3 2019 Nov 06, 2019	BUY	$13.89 - $23.16 $430,590 - $717,960	31,000 Added 23.99%	160,200 $2.43 Million

Q2 2019 Aug 08, 2019	BUY	$16.27 - $20.51 $21,151 - $26,663	1,300 Added 1.02%	129,200 $2.51 Million
Q1 2019 May 08, 2019	BUY	$12.61 - $22.33 $249,678 - $442,133	19,800 Added 18.32%	127,900 $2.66 Million
Q4 2018 Feb 07, 2019	BUY	$12.41 - $22.98 $1.34 Million - $2.48 Million	108,100 New	108,100 $1.47 Million

187

88.1M

528K

219K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $319M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of Rational Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Rational Advisors LLC with notifications on news.